我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
5
0 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
2008
已完成
4
80.0%
Unknown
1
20.0%
暂无批准数据
- A major meta-analysis led by the University of Birmingham found that nitrous oxide treatment can provide rapid relief for patients with major depressive disorder and treatment-resistant depression within 24 hours. - Single treatments at 50% concentration showed significant short-term improvements, while repeated dosing over several weeks led to more durable benefits for maintaining clinical improvement. - The treatment targets glutamate receptors similar to ketamine and could offer new hope for the approximately 48% of UK patients who don't respond to standard antidepressants. - Researchers are now preparing the first NHS trial in the UK to assess nitrous oxide's safety and acceptability as a depression treatment for clinical integration.